If you have been diagnosed with prostate cancer, a doctor will combine the results of their digital rectal exam (DRE), prostate-specific antigen (PSA) and Gleason score from their biopsy to determine whether their cancer has a chance of spreading (metastasizing) beyond the prostate gland. The compiled data is then used to determine if an imaging test is required to search for any potential spread of prostate cancer.